This residual sensitivity suggests the existence of a cyclin D1 substrate outside the pRB family, or perhaps a noncanonical cyclin D1 function (38–44), governing the response of ccRCC to PT2399. The gene discussed is CCND1; the disease is nonpapillary renal cell carcinoma.